- Home
- NYMT vs EYPT Comparison
NYMT vs EYPT Comparison
Compare NYMT & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYMT
- EYPT
- Stock Information
- Founded
- NYMT 2003
- EYPT 1987
- Country
- NYMT United States
- EYPT United States
- Employees
- NYMT N/A
- EYPT N/A
- Industry
- NYMT Real Estate Investment Trusts
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- NYMT Real Estate
- EYPT Industrials
- Exchange
- NYMT Nasdaq
- EYPT Nasdaq
- Market Cap
- NYMT 539.9M
- EYPT 439.4M
- IPO Year
- NYMT 2004
- EYPT 2005
- Fundamental
- Price
- NYMT $5.96
- EYPT $9.17
- Analyst Decision
- NYMT Buy
- EYPT Strong Buy
- Analyst Count
- NYMT 5
- EYPT 8
- Target Price
- NYMT $7.88
- EYPT $27.29
- AVG Volume (30 Days)
- NYMT 934.7K
- EYPT 1.1M
- Earning Date
- NYMT 10-30-2024
- EYPT 11-07-2024
- Dividend Yield
- NYMT 13.42%
- EYPT N/A
- EPS Growth
- NYMT N/A
- EYPT N/A
- EPS
- NYMT N/A
- EYPT N/A
- Revenue
- NYMT $252,541,000.00
- EYPT $45,713,000.00
- Revenue This Year
- NYMT N/A
- EYPT N/A
- Revenue Next Year
- NYMT $26.56
- EYPT N/A
- P/E Ratio
- NYMT N/A
- EYPT N/A
- Revenue Growth
- NYMT 139.48
- EYPT 7.50
- 52 Week Low
- NYMT $5.14
- EYPT $5.86
- 52 Week High
- NYMT $9.67
- EYPT $30.99
- Technical
- Relative Strength Index (RSI)
- NYMT 57.22
- EYPT 38.25
- Support Level
- NYMT $5.57
- EYPT $11.26
- Resistance Level
- NYMT $6.23
- EYPT $12.23
- Average True Range (ATR)
- NYMT 0.22
- EYPT 0.97
- MACD
- NYMT 0.06
- EYPT -0.30
- Stochastic Oscillator
- NYMT 75.23
- EYPT 3.24
About NYMT New York Mortgage Trust Inc.
New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.